(NASDAQ:EXEL),(NASDAQ:LEGN),(NASDAQ:AKRO), DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) — SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the appointments of Charles “Chip” R. Romp and Tom J. Heyman to its Board of Directors. These appointments further align SynOx's business […]

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Billy Goat is pleased to announce the launch of the new Z3002 and X3002 Hurricane(TM) Stand-On Blowers. These models are built upon the robust performance of the prior 3001 series, incorporating significant new and carried-over upgrades focused on increasing durability, enhancing operator comfort, and improving ease of

(TSX:NPK),(OTC US:VNPKF),(Other OTC:VNPKF), SINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF) (“Verde” or the “Company“), is pleased to report ionic-adsorption behaviour confirmed across multiple trenches at the Minas Americas Global Alliance Project (“Minas Americas” or the “Project”) in Minas Gerais, Brazil. Ammonium-sulfate leach tests returned primary leach solutions

Recurrent Energy's latest solar and energy storage projects support Arizona Public Service's record power needs Recurrent Energy, a subsidiary of Canadian Solar Inc.(“Canadian Solar”) (NASDAQ: CSIQ) and a global developer, owner, and operator of solar and energy storage assets, today announced it has closed $825 million in construction financing and tax equity for its Desert

(NasdaqGM:SION), SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that

SHANGHAI and WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Hengrui Pharma (Hengrui), a global pharmaceutical company focused on scientific and technological innovation, and Kailera Therapeutics, Inc. (Kailera), a clinical-stage biopharmaceutical company focused on advancing a differentiated, late-stage portfolio of next-generation therapies for the treatment of obesity, today announced an oral presentation at ObesityWeek(R) 2025,

DES MOINES, Iowa, Oct. 21, 2025 (GLOBE NEWSWIRE) — Dwolla, a leading provider of account-to-account (A2A) payment infrastructure trusted by fintechs and enterprises, today announced its participation at Money20/20 USA, where the company will spotlight its Instant Payments capabilities across the RTP(R) network and the FedNow(R) Service. With Dwolla's latest offering, platforms can use Dwolla's

Zurich, Oct. 21, 2025 (GLOBE NEWSWIRE) — Today Chipmind, the first European startup building AI agents to accelerate the development of microchips, launches Chipmind Agents, optimized to empower engineering teams in semiconductor companies to speed-up the path from specification to chip manufacturing. Chipmind Agents are a new class of AI agents designed to automate and

METRO Inc. will release its fourth quarter fiscal 2025 results on November 19, 2025. The release will be followed by a conference call at 9:00 a.m. (EST). Mr. Eric R. La Flèche, President & CEO and Mr. Nicolas Amyot, Executive Vice President & CFO will hold a conference call intended for investors and financial analysts

Transfr Launches XR-Based, Multimodal Programs and New Platform Capabilities to Advance Students and Adult Learners from Classroom to Career Today, Transfr Inc., the leading workforce education company, launches Transfr Train, a collection of XR-based, multimodal career training programs, alongside major platform enhancements including financial literacy tools, expanding its pioneering career mobility system. https://mma.prnewswire.com/media/2801250/Transfr_Logo.jpg “Millions of